| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Vikram Ravindra Mamidipudi
Appointed as Director since March 2015 |
Director | 27-Mar-2015 | Current |
|
Premium access
Complete director detailsUnlock the complete director and KMP records available for Evertogen Life Sciences Limited.
Verified entity values are shown only after access is granted. |
|||
|
Manav Jassal
Appointed as Director since January 2013 |
Director | 11-Jan-2013 | Current |
|
Subbarao Kattamuri
Appointed as Managing Director since January 2013 |
Managing Director | 11-Jan-2013 | Current |
|
Sherifuddin Sheriff Shaik
Appointed as Director since December 2023 |
Director | 06-Dec-2023 | Current |
|
Sushma Kattamuri
Appointed as Director since January 2022 |
Director | 05-Jan-2022 | Current |
|
Sat Paul Jassal
Appointed as Director since June 2021 |
Director | 18-Jun-2021 | Current |
|
Akhila Thotapally
Appointed as Company Secretary since July 2025 |
Company Secretary | 22-Jul-2025 | Current |
People Timeline
Explore the timeline of key personnel in Evertogen Life Sciences Limited's leadership journey.
Loading...
Contact Details
- Address 7-2-C8 & C8/2, G V Chambers, Sanath Nagar Ida Sanath Nagar, Hyderabad Telangana, 500018, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 500018
- Country India
- Website evertogen.com
Frequently Asked Questions
You can contact Evertogen Life Sciences Limited through their registered address at 7-2-C8 & C8/2, G V Chambers, Sanath Nagar Ida Sanath Nagar, Hyderabad Telangana, 500018, India, or via their website at evertogen.com. Social media links are also provided where applicable.
The current directors of Evertogen Life Sciences Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- MANAV JASSAL
- SUBBARAO KATTAMURI
- SHERIFUDDIN SHERIFF SHAIK
- VIKRAM RAVINDRA MAMIDIPUDI
- SUSHMA KATTAMURI
- SAT PAUL JASSAL
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.